Hypertension in the elderly population;La hipertensión arterial en la población anciana

Revista Espanola de Geriatria y Gerontologia

Volumn 43, Issue SUPPL.2, 2008, Pages 53-59

  Sierra, Cristina ^a   López Soto, Alfonso ^a   Coca, Antonio ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Ageing; Comorbidity; Isolated systolic hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGED; AGING; ARTICLE; HUMAN; HYPERTENSION;

AGED; AGING; ANTIHYPERTENSIVE AGENTS; HUMANS; HYPERTENSION;

EID: 67649795579     PISSN: 0211139X     EISSN: 15781747     Source Type: Journal    
DOI: 10.1016/S0211-139X(08)76130-4     Document Type: Article

References (26)

1. National High Blood Pressure Education Program Working Group. National High Blood Pressure Education Program Working Group report on hypertension in the elderly. Hypertension. 1993;23:275-85.
2. Domanski MJ, Davis BR, Pfeffer MA, Kastantin M, Mitchell GF. Isolated systolic hypertension. Prognostic information provided by pulse pressure. Hypertension. 1999;34:375-80.
3. MacMahon S, Rodgers A. The effects of blood pressure reduction in older patients: an overview of five randomized controlled trials in elderly hypertensives. Clin Exp Hypertens. 1993;15:967-78.
4. Banegas JR, Rodríguez-Artalejo F, Ruilope LM, Graciano A, Lique M, De la Cruz JJ, et al. Hypertension magnitude and management in the elderly population of Spain. J Hypertens. 2002;20:2157-64.
5. Coca A. Evolución del control de la hipertensión arterial en atención primaria en España. Resultados del estudio Controlpres 2003. Hipertensión. 2005;22:5-14.
6. Banegas JR, De la Cruz JJ, Rodríguez-Artalejo F, Graciani A, Guallar P, Herruzo R. Systolic vs. diastolic blood pressure: community burden and impact on blood pressure staging. J Hum Hypertens. 2002;16:163-7.
7. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 2001;345:479-86.
8. Kannel WB. Elevated systolic blood pressure as a cardiovascular risk factor. Am J Cardiol. 2000;85:251-5.
9. Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 319000 white men in the multiple risk Factor Intervention Trial (MRFIT). Arch Intern Med. 1992;152:56-64.
10. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly program (SHEP). JAMA. 1991;265:3255-64.
11. Staessen JA, Fagard R, Thijs L, Celis H, Arabidzr GG, Birkenhäger WH, et al, for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet. 1997;350:757-64.
12. Liu L, Wang JG, Gong L, Liu G, Staessen JA. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group. J Hypertens. 1998;16:1823-9.
13. Staessen JA, Wang JG, Thijs L, Fagard R. Overview of the outcome trials in older patients with isolated systolic hypertension. J Hum Hypertens. 1999;13:859-63.
14. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al. Treatment of hipertension in patients 80 years of age or older. N Engl J Med. 2008;358:1-12.
15. Sierra C. Hipertensión arterial en el anciano. Cardiol Práct (Barc). 2003;12:4-10.
16. Whelton PK, Appel LJ, Espeland MA, for the TONE collaborative research group. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA. 1998;279:839-46.
17. World Health Organization-International Society of Hypertension 1999. Guidelines for the management of hypertension. J Hypertens. 1999;17:151-83.
18. Mancia G, De Backer G, Dominiczak A, et al. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens. 2007;25:1751-62.
19. Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensve blood- pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet. 1998;351:1755-62.
20. Senior H, Anderson CS, Chen M, Daoḧlf B, Eimfeldt D, Julius S,, et al. Management of hypertension in the oldest old: a study in primary care in New Zealand. Age Ageing. 2006;35:178-82.
21. Gueyffier F, Bilpitt C, Boissel JP, Schron E, Ekbon T, Fagard R, et al. Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group. Lancet. 1999;353:793-6.
22. Van Bemmel T, Gussekloo J, Westendorp RGJ, Blauw GJ. In a population- based prospective study, no association between high blood pressure and mortality after age 85 years. J Hypertens. 2006;24:287-92.
23. Bulpitt CJ, Beckett NS, Cooke J, Dumistrascu DL, Gil-Extremera B, Nachov C, et al. Results of the pilot study for the Hypertension in the Very Elderly Trial. J Hypertens. 2003;21:2409-17.
24. Amery A, Birkenhäger W, Brixko P, for the European Working Party on High Blood Pressure Research in the Elderly. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial. Lancet. 1985;1:1349-54.
25. Medical Research Council Working Party. Medical Research Council Trial of treatment of hypertension in older adults: principal results. BMJ. 1992;304;405-12.
26. Dälhof B, Lindholm LH, Hansson L, Scherstén B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet. 1991;338:1281-5.